Taiwan Liposome Company General Manager George Yeh: An Interview With PharmAsia News (Part 1 Of 2)
This article was originally published in PharmAsia News
Executive Summary
Taiwan Liposome Company General Manager George Yeh recently spoke with PharmAsia News about the drug delivery company's partnership strategy and its plans to expand beyond Southeast Asia. TLC, based in South San Francisco and Taipei, is engaged in research, development and commercialization of proprietary drug delivery systems for improving the treatment of cancer, ophthalmic conditions and infectious diseases.